Krystal Biotech, Inc. logo KRYS - Krystal Biotech, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 17
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $336.40 DETAILS
HIGH: $371.00
LOW: $300.00
MEDIAN: $327.00
CONSENSUS: $336.40
DOWNSIDE: 10.31%

Profitability Ratios

Ratio Value
GP Margin 92.6%
EBIT Margin 48.7%
EBITDA Margin 50.4%
Operating Margin 41.5%
Pretax Margin 48.7%
Cont. Ops Margin 52.6%
Net Margin 52.6%
Bottom Line Margin 52.6%

Liquidity Ratios

Ratio Value
Current Ratio 9.95
Quick Ratio 9.56
Solvency Ratio 1.850
Cash Ratio 4.82

Valuation Ratios

Ratio Value
Price/Earnings
34.82
Hist. avg: 42.5
Peers avg: 26.9
PEG Ratio 0.27
Forward PEG 0.27
Price/Book 5.85
Price/Sales 18.34
Price/FCF 37.77
Price/Op Cash Flow 35.53

Debt Ratios

Ratio Value
Debt/Assets 0.0070
Debt/Equity 0.0077
Debt/Capital 0.0076
Long-Term Debt/Capital 0.0000
Financial Leverage 1.09

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.50
Operating Cash Flow Ratio 1.951
Operating Cash Flow/Sales 51.6%
Free Cash Flow/Operating Cash Flow 94.1%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 21.51
Capital Expenditure Coverage 16.81
Dividend + Capital Expenditure Coverage 16.81

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 13.44
EPS 7.077
Debt/Share 0.3227
Cash/Share 28.60
Book Value/Share 42.14
Tangible BV/Share 42.14
Equity/Share 42.14
Operating Cash Flow/Share 6.940
Capital Expenditure/Share 0.413
FCF/Share 6.527

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.081
Earnings Before Tax/EBIT 1.175
Price/Fair Value 5.85
Debt/Market Cap 0.0000
Effective Tax Rate -8.1%
Enterprise Value Multiple 33.92